C. Difficile

>

Latest News

Outpatient <i>C difficile</i> Cases Reveal Diagnostic Gaps and PPI-Linked Risks
Outpatient <i>C difficile</i> Cases Reveal Diagnostic Gaps and PPI-Linked Risks

June 20th 2025

At ASM Microbe 2025, researchers underscored the role of NAAT in outpatient CDI diagnosis and raised concerns over PPI-related risk in older, health care–associated cases.

Evolving Challenges in <i>C difficile</i> Testing: Diagnostic Stewardship or Laboratory Retrogression?
Evolving Challenges in <i>C difficile</i> Testing: Diagnostic Stewardship or Laboratory Retrogression?

June 19th 2025

MAD-ID 2025 Highlights Fidaxomicin’s Role in Reducing C difficile Recurrence
MAD-ID 2025 Highlights Fidaxomicin’s Role in Reducing C difficile Recurrence

June 10th 2025

New Genomic Study Findings Reveal Hidden Pathways of <i>C difficile</i> Transmission in Hospitals
New Genomic Study Findings Reveal Hidden Pathways of <i>C difficile</i> Transmission in Hospitals

April 4th 2025

Investigational Oral Biologic Achieves 100% <i>C difficile</i> Clinical Cure in Preliminary Cohort
Investigational Oral Biologic Achieves 100% <i>C difficile</i> Clinical Cure in Preliminary Cohort

April 3rd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.